Share
Vaccines Market Size, Share, and Analysis, By Technology (Conjugate, Recombinant, Live Attenuated, Toxoid, Viral Vector, and mRNA), By Type (Monovalent and Multivalent), By Disease (Pneumococcal, Flu, HPV, Herpes Zoster, MMR, Rotavirus, and RSV), By Route of Administration (Parenteral and Oral), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
Vaccines Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 66.4 billion and is projected to reach USD 122.8 billion by the completion of 2034.
Vaccines are biological preparations designed to boost the immune system and protect against infectious diseases. They consist of weakened or inactivated versions of disease-causing pathogens, such as viruses or bacteria, or components of these agents. When vaccines are administered, the body's immune system identifies the unfamiliar elements and generates antibodies and other active measures to fight against them. This method prepares the immune system to react efficiently in case of future exposure to the real pathogen, thereby averting or reducing the severity of the disease. Therefore, vaccinations are among the most effective public health measures, which annually save millions of lives by averting various diseases such as polio, measles, flu, and most recently, COVID-19.
Vaccine market is projected to reach USD 122.8 billion over the forecast period, due to several factors such as the COVID-19 pandemic, various breakthroughs in technology, and growing awareness of the importance of immunization. Industry players are heavily invested in research and development, which leads to the introduction of new vaccines targeting a wide range of infectious diseases. In addition, the vaccine market has witnessed a rise in demand for COVID-19 vaccines, with companies like Pfizer, Moderna, and AstraZeneca playing important roles in their development and distribution. Besides, the resurgence of infectious diseases like influenza and the growing incidences of chronic diseases have generated the need for preventive measures. Furthermore, collaborations between pharma companies and government agencies have assisted in the development of new vaccine candidates.
Source: Fatpos Global
Vaccine market is divided by Technology into Conjugate, Recombinant, Live Attenuated, Toxoid, Viral Vector, and mRNA. During the COVID-19 pandemic, mRNA vaccines have become dominant in the vaccine market due to their fast creation and efficiency. mRNA vaccines are not like traditional vaccinations in that they use synthetic mRNA to guide cells to produce the required antigen, hence inducing an immune response. This technology makes it easier to adapt to new viral mutations and allow for faster manufacturing. Moreover, mRNA vaccines have demonstrated strong efficacy and safety records, which have contributed to their vast market adoption. Thus, their success with COVID-19 has attracted more research and funding, which improved the position of mRNA segment in the vaccine industry.
Vaccine market is divided by Route of Administration into Parenteral and Oral. The parenteral route of administration segment is anticipated to capture the highest market share and include vaccines given via injections or intravenous routes. Parenteral vaccines go directly into the bloodstream without passing through the digestive system and produce a more powerful immune response than oral vaccines. They show better stability and shelf life since they are not exposed to the damaging effects of stomach acids and digestive enzymes. In addition, several commonly used vaccines like the ones for flu, hep B, and COVID-19 are offered in injectable forms. Moreover, administering vaccines parenterally also ensures accurate dosing as it eliminates the potential problems of inadequate ingestion or absorption seen with oral vaccines. As a result, directing vaccines to tissues or muscles can improve the immune response, thus strengthening the position of the parenteral segment in the vaccine market.
Source: Fatpos Global
Innovations in Medical Technology Fuels the Growth of Vaccines Market
Constant innovations in medical technology have been significant for the growth of the global vaccine market. Numerous developments in creating vaccines, such as the adoption of mRNA technology, have resulted in the production of vaccines that are more potent and faster to produce. The mRNA-based COVID-19 vaccines from Pfizer and Moderna were created within months, which demonstrates the abilities of mRNA technology. In addition, several breakthroughs in adjuvants, or immune response enhancers, along with vaccine delivery techniques have further improved the success rate and availability of vaccinations to the common public.
Growing Awareness and Government Efforts are Promoting the Need for Vaccines
Growing understanding of the importance of vaccination, coupled with several efforts by the government, has played a primary role in the growth of the global vaccine market. Public health campaigns and educational initiatives hold a large importance in promoting vaccination, which has increased the demand for vaccination drives. Also, governments across the world have implemented vaccination campaigns and framed several laws, which have improved the accessibility and cost of vaccines in developing countries. Furthermore, in addition to growing immunization rates, these initiatives by the governments have offered vaccine producers easy access to new markets.
Vaccine Hesitancy and Misinformation in the Vaccines Market
Even though vaccines offer several benefits, vaccine hesitancy and the circulation of false information are presenting major challenges for the global vaccine market. Certain people are worried about the safety or effectiveness of vaccines due to inaccurate or deceptive information spread online or through other sources. This reluctance can result in lower rates of vaccination, which could ultimately impact the expansion of the vaccine market and present various risks to public health. Therefore, educating the public, being transparent, and establishing trust in scientific evidence are important for the continuous success of the vaccine market and for reducing vaccine hesitancy.
Vaccines Market is segmented based on regional analysis into five key regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The global vaccine market is controlled by the North American region due to multiple reasons. The existence of large pharmaceutical companies and well-established R&D centers in the area has played a major role in the advancement of different vaccines. Also, favorable government policies and high knowledge of preventative healthcare have contributed to the implementation of vaccination initiatives in North America.
Concurrently, the vaccine market in the Asia-Pacific is the second fastest-growing across the world. The large population, along with growing healthcare spending has improved the vaccination rates. Moreover, countries such as China and India, which are known for their large populations, offer major market potential for vaccine producers.
Source: Fatpos Global
Global vaccines market experienced a substantial boost in growth and transformation due to the impact of the COVID-19 pandemic. The persistent demand for a successful vaccine for the new coronavirus led to extraordinary levels of research, cooperation, and funding from pharmaceutical companies, governments, and research institutions globally. In addition, the focused attention and allocation of resources speeded up the creation and distribution of highly efficient COVID-19 vaccines by using advanced technologies such as mRNA and adenovirus vectors. Moreover, the importance of vaccine manufacturing capabilities and supply chains was highlighted by the pandemic, which further resulted in more funding for production facilities and infrastructure. Therefore, the COVID-19 crisis emphasized the significance of vaccines in protecting global health and pushed the vaccine industry into a new phase of growth.
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2018-2034 |
|
Base Year |
2023 |
|
Forecast Period |
2024-2034 |
|
Historical Period |
2019-2022 |
|
Growth Rate |
CAGR of 5.7% from 2024-2034 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
Main Segments List |
|
By Technology |
|
|
By Type |
|
|
By Disease |
|
|
By Route of Administration |
|
|
By Region |
|
The vaccine Market size was valued at USD 66.4 billion in 2023 and is projected to reach the value of USD 122.8 billion in 2034, exhibiting a CAGR of 5.7% during the forecast period.
The vaccine market refers to the global industry involved in the research, development, manufacturing, and distribution of various types of vaccines.
The mRNA segment and Parenteral segment accounted for the largest vaccine market share.
Key players in the Vaccines Market include Pfizer, GlaxoSmithKline (GSK), Merck & Co., Sanofi Pasteur, Serum Institute of India, AstraZeneca, Novavax, Moderna, Johnson & Johnson, CSL Limited, Bharat Biotech, Sinovac Biotech, CanSino Biologics, Dynavax Technologies, Valneva., and Other Prominent Players.
Innovations in medical technology, along with growing awareness and government efforts are the factors driving the vaccines market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
